生命科学资讯

NIH imposes full ban of aborted fetal tissue in research

High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’

Investors load Corxel with $287M for a ‘differentiated’ obesity pill

Drugmakers spent less on Washington lobbying in 2025's final quarter

Bristol Myers buys into Janux’s ‘masked’ T cell engagers

Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing

FDA lays out new path to speed development of multiple myeloma drugs

Corcept's drug extends patients' lives in key ovarian cancer study

BioMarin vets form Mendra to ‘modernize’ rare disease drug development

China-founded pharma Corxel raises up to $287M for oral GLP-1

Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2

Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target

Mechanistic insights into fatty acid odor detection mediated by class II olfactory receptors

BMS pens $850M solid tumor pact with T-cell engager biotech Janux

Corcept racks up phase 3 cancer win to bounce back from FDA Cushing's rejection

Corxel secures $287M series D to fund phase 2/3 obesity studies of oral GLP-1 drug

Hoth strikes back against cancer drug skin toxicities, but share price stays frozen

Health insurance CEOs head to DC

Roche boosts NC factory investment to $2B; Rentschler CEO steps down

Another biopharma tried buying Amicus before BioMarin's $4.8B deal